Danicopan: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Danicopan. Educational only — not medical advice.
Labeled uses
VOYDEYA is indicated as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular hemolysis (EVH) in adults with paroxysmal nocturnal hemoglobinuria (PNH).
Source: FDA labeling via NIH DailyMed (set ab8d1cbd…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.